CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $36,000 | -36.8% | 203,548 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | -28.8% | 203,548 | -13.3% | 0.00% | – |
| Q1 2022 | $80,000 | +281.0% | 234,892 | +689.3% | 0.00% | – |
| Q4 2021 | $21,000 | -52.3% | 29,758 | 0.0% | 0.00% | – |
| Q3 2021 | $44,000 | -57.7% | 29,758 | -31.8% | 0.00% | – |
| Q1 2021 | $104,000 | – | 43,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beacon Financial Advisory LLC | 40,000 | $14,000 | 0.01% |
| Virtu Financial LLC | 111,749 | $38,000 | 0.00% |
| Alpha Cubed Investments, LLC | 10,000 | $3,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 25,143 | $9,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 10 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 12,163 | $4,000 | 0.00% |
| NORTHERN TRUST CORP | 32,094 | $11,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 129,016 | $43,000 | 0.00% |
| STATE STREET CORP | 19,645 | $7,000 | 0.00% |